Tandem Diabetes Care Inc (TNDM) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

Total Cash From Operating Activities Chart for Tandem Diabetes Care Inc

Tandem Diabetes Care Inc (TNDM) operating cash flow for FY2025 was USD -9.7M, a -140.1% change from FY2024. Tandem Diabetes Care Inc's operating cash flow moved from USD -21.5M in 2011 to USD -9.7M in 2025 over 14 years.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.21B
Implied Share Price
$17.43
Enterprise Value
$1.02B
Revenue (TTM)
$1.04B
EBITDA
-$25.03M
Profit Margin
-6.08%
Trailing P/E
—
Forward P/E
1111.11
Price/Book (MRQ)
6.65
Price/Sales (TTM)
1.16
EV/EBITDA
345.75
EV/Revenue
1.02
Dividend Yield
—
Book Value
$1.88
Free Cash Flow (FY2025)
-$29.67M
Free Cash Flow Yield
-2.45%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.